|
ATE448784T1
(de)
*
|
2002-02-14 |
2009-12-15 |
Pharmacia Corp |
Substituierte pyridinone als modulatoren für p38 map kinase
|
|
US7456222B2
(en)
*
|
2002-05-17 |
2008-11-25 |
Sequella, Inc. |
Anti tubercular drug: compositions and methods
|
|
US20040033986A1
(en)
*
|
2002-05-17 |
2004-02-19 |
Protopopova Marina Nikolaevna |
Anti tubercular drug: compositions and methods
|
|
CN101404986B
(zh)
*
|
2002-05-17 |
2011-09-28 |
赛奎拉公司 |
用于诊断和治疗感染性疾病的组合物和制药方法
|
|
EP1405849A1
(en)
*
|
2002-10-04 |
2004-04-07 |
Corning Incorporated |
Halogenated styrene compounds and low-absorption-loss polymers obtainable therefrom
|
|
CL2004002050A1
(es)
*
|
2003-08-13 |
2005-06-03 |
Pharmacia Corp Sa Organizada B |
Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
|
|
WO2005034857A2
(en)
*
|
2003-09-05 |
2005-04-21 |
Sequella, Inc. |
Methods and compositions comprising diamines as new anti-tubercular therapeutics
|
|
CN100358872C
(zh)
*
|
2003-11-14 |
2008-01-02 |
上海睿星基因技术有限公司 |
吡啶酮衍生物及其应用
|
|
CN1905873A
(zh)
*
|
2003-11-19 |
2007-01-31 |
阵列生物制药公司 |
Mek的杂环抑制剂及其使用方法
|
|
MXPA06007326A
(es)
|
2003-12-23 |
2007-01-26 |
Astex Therapeutics Ltd |
Derivados de pirazol como moduladores de proteina cinasa.
|
|
CN1930126A
(zh)
|
2004-03-05 |
2007-03-14 |
万有制药株式会社 |
吡啶酮衍生物
|
|
EP1741702A1
(en)
*
|
2004-04-28 |
2007-01-10 |
Ono Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compounds and medicinal use thereof
|
|
TWI355380B
(en)
*
|
2004-05-27 |
2012-01-01 |
Nihon Nohyaku Co Ltd |
Substituted pyrazinecarboxanilide derivatives or s
|
|
JP4853759B2
(ja)
*
|
2004-05-27 |
2012-01-11 |
日本農薬株式会社 |
置換ピラジンカルボン酸アニリド誘導体又はその塩類、その中間体及び農園芸用薬剤並びにその使用方法
|
|
EA012119B1
(ru)
|
2004-08-12 |
2009-08-28 |
Пфайзер Инк. |
ПРОИЗВОДНЫЕ ТРИАЗОЛОПИРИДИНСУЛЬФАНИЛА В КАЧЕСТВЕ ИНГИБИТОРОВ p38 MAP КИНАЗЫ
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
EP1802590A1
(en)
*
|
2004-10-13 |
2007-07-04 |
Pharmacia & Upjohn Company LLC |
Substituted n-alkylpyrimidinones
|
|
US7713998B2
(en)
|
2004-11-10 |
2010-05-11 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenous heterocyclic compound and pharmaceutical use thereof
|
|
EP1838675A1
(en)
*
|
2004-11-24 |
2007-10-03 |
Laboratoires Serono S.A. |
Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders
|
|
PT1828160E
(pt)
|
2004-12-21 |
2012-01-05 |
Merck Serono Sa |
Derivados cíclicos de sulfonilamino e sua utilização
|
|
RS51957B
(sr)
|
2005-01-31 |
2012-02-29 |
Merck Serono Sa. |
Derivati n-hidroksiamida i njihova upotreba
|
|
ES2600460T3
(es)
*
|
2005-05-10 |
2017-02-09 |
Intermune, Inc. |
Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
|
|
US8343953B2
(en)
|
2005-06-22 |
2013-01-01 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
WO2006136837A2
(en)
|
2005-06-23 |
2006-12-28 |
Astex Therapeutics Limited |
Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
|
|
TW200740755A
(en)
*
|
2005-07-13 |
2007-11-01 |
Bayer Cropscience Sa |
Dihalogenation of N,O-disubstituted hydroxypyridones and their uses
|
|
JPWO2007018248A1
(ja)
|
2005-08-10 |
2009-02-19 |
萬有製薬株式会社 |
ピリドン化合物
|
|
WO2007024004A1
(ja)
|
2005-08-24 |
2007-03-01 |
Banyu Pharmaceutical Co., Ltd. |
フェニルピリドン誘導体
|
|
ATE548363T1
(de)
|
2005-08-29 |
2012-03-15 |
Vertex Pharma |
3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen
|
|
EP1919906B1
(en)
|
2005-08-29 |
2011-10-12 |
Vertex Pharmaceuticals Incorporated |
3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
|
|
JP5112317B2
(ja)
*
|
2005-08-29 |
2013-01-09 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
非受容体型チロシンキナーゼのｔｅｃファミリーの阻害剤として有用な３，５−二置換ピリド−２−オン
|
|
EA013816B1
(ru)
|
2005-09-01 |
2010-08-30 |
Арес Трейдинг С.А. |
Лечение неврита зрительного нерва
|
|
WO2007029847A1
(ja)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
二環性芳香族置換ピリドン誘導体
|
|
US7973060B2
(en)
*
|
2005-10-13 |
2011-07-05 |
Crystalgenomics, Inc. |
Fab I inhibitor and process for preparing same
|
|
AR059898A1
(es)
*
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
|
US7718830B2
(en)
|
2006-04-24 |
2010-05-18 |
Allergan, Inc. |
Abnormal cannabidiols as agents for lowering intraocular pressure
|
|
AU2007244978B2
(en)
*
|
2006-04-24 |
2013-05-30 |
Allergan, Inc. |
Abnormal Cannabidiols as agents for lowering intraocular pressure
|
|
US7618966B2
(en)
|
2006-04-24 |
2009-11-17 |
Allergan, Inc. |
Abnormal Cannabidiols as agents for lowering intraocular pressure
|
|
UY30378A1
(es)
*
|
2006-06-02 |
2008-01-02 |
Janssen Pharmaceutica Nv |
Nuevos derivados de piridinona n-aril y n-heteroaril sustituidos para usar en enfermedades mediadas por mch-1
|
|
WO2007143597A2
(en)
*
|
2006-06-05 |
2007-12-13 |
Novartis Ag |
Organic compounds
|
|
ES2426780T3
(es)
*
|
2006-07-14 |
2013-10-25 |
Amgen Inc. |
Compuestos de piridona sustituidos con alquino y métodos de uso
|
|
KR20090047542A
(ko)
|
2006-08-25 |
2009-05-12 |
베링거 인겔하임 인터내셔날 게엠베하 |
Ｍｃｈ 길항 활성을 갖는 신규한 피리돈 유도체 및 당해 화합물을 포함하는 의약
|
|
WO2008041090A1
(en)
*
|
2006-10-06 |
2008-04-10 |
Pfizer Limited |
Malanin concentrating hormone receptor-1 antagonist pyridinones
|
|
WO2008071646A1
(en)
|
2006-12-11 |
2008-06-19 |
Boehringer Ingelheim International Gmbh |
New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds
|
|
ATE556055T1
(de)
|
2006-12-13 |
2012-05-15 |
Pfizer Prod Inc |
Verfahren zur herstellung von 3-(4-(2,4- difluorbenzyloxy)-3-brom-6-methyl- 2-oxopyridin- 1(2h)-yl)-n,4-dimethylbenzamid
|
|
EP2518063B1
(en)
*
|
2006-12-21 |
2017-02-01 |
Sloan-Kettering Institute For Cancer Research |
Pyridazinones and furan-containing compounds
|
|
KR20090097214A
(ko)
*
|
2007-01-10 |
2009-09-15 |
알바니 몰레큘라 리써치, 인크. |
5-푸로피리디논 치환된 인다졸
|
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
|
GB0704932D0
(en)
|
2007-03-14 |
2007-04-25 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
WO2008157786A1
(en)
|
2007-06-20 |
2008-12-24 |
Auspex Pharmaceutical, Inc. |
Substituted n-aryl pyridinones as fibrotic inhibitors
|
|
EA016595B1
(ru)
*
|
2007-07-17 |
2012-06-29 |
Бристол-Маерс Сквибб Компани |
Способ модулирования рецептора gpr119, сопряженного с g-белком, и используемые при этом соединения
|
|
SI2203439T1
(sl)
|
2007-09-14 |
2011-05-31 |
Ortho Mcneil Janssen Pharm |
1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni
|
|
CN101801930B
(zh)
|
2007-09-14 |
2013-01-30 |
奥梅-杨森制药有限公司 |
1,3-二取代的-4-苯基-1h-吡啶-2-酮
|
|
PL2200985T3
(pl)
|
2007-09-14 |
2011-12-30 |
Ortho Mcneil Janssen Pharmaceuticals Inc |
1,3-Dipodstawione-4-(arylo-X-fenylo)-1H-pirydyn-2-ony
|
|
MY156662A
(en)
*
|
2007-11-01 |
2016-03-15 |
Acucela Inc |
Amine derivative compounds for treating ophthalmic diseases and disorders
|
|
CN101861316B
(zh)
|
2007-11-14 |
2013-08-21 |
奥梅-杨森制药有限公司 |
咪唑并[1,2-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
|
|
KR20100088142A
(ko)
*
|
2007-11-20 |
2010-08-06 |
머크 샤프 앤드 돔 코포레이션 |
비-뉴클레오사이드 역전사효소 억제제
|
|
US20090281054A1
(en)
*
|
2008-05-06 |
2009-11-12 |
Venkata Reddy |
Compositions and methods comprising capuramycin analogues
|
|
CN102099036B
(zh)
|
2008-06-03 |
2015-05-27 |
英特芒尼公司 |
用于治疗炎性疾患和纤维化疾患的化合物和方法
|
|
EP2344470B1
(en)
|
2008-09-02 |
2013-11-06 |
Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
|
AU2009290474A1
(en)
|
2008-09-11 |
2010-03-18 |
Pfizer Inc. |
Heteroaryls amide derivatives and their use as glucokinase activators
|
|
WO2010043396A1
(en)
|
2008-10-16 |
2010-04-22 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
|
JP5690277B2
(ja)
|
2008-11-28 |
2015-03-25 |
ジャンセン ファーマシューティカルズ， インコーポレイテッド． |
代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
|
|
EP2389374A1
(en)
|
2009-01-20 |
2011-11-30 |
Pfizer Inc. |
Substituted pyrazinone amides
|
|
EP2604604A1
(en)
|
2009-03-11 |
2013-06-19 |
Pfizer Inc |
Benzofuranyl derivatives used as glucokinase inhibitors
|
|
BRPI1010831A2
(pt)
|
2009-05-12 |
2016-04-05 |
Addex Pharmaceuticals Sa |
derivados de 1,2,4-triazolo[4,3-a]piridina e seu como moduladores alostéricos positivos de receptores de mglur2
|
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
|
CN102439008B
(zh)
|
2009-05-12 |
2015-04-29 |
杨森制药有限公司 |
1,2,4-三唑并[4,3-a]吡啶衍生物及其用于治疗或预防神经和精神病症的用途
|
|
KR101478133B1
(ko)
|
2009-05-25 |
2014-12-31 |
센트럴 사우스 유니버시티 |
1-（치환된 벤질기）-5-트리플루오로메틸-2-（1ｈ）피리돈 화합물 및 그 염의 제조방법 및 용도
|
|
WO2010135972A1
(zh)
|
2009-05-25 |
2010-12-02 |
中南大学 |
1-(取代芳基)-5-三氟甲基-2-（1h）吡啶酮化合物及其盐的制备方法及其用途
|
|
US20110021570A1
(en)
|
2009-07-23 |
2011-01-27 |
Nancy-Ellen Haynes |
Pyridone glucokinase activators
|
|
CN101973936B
(zh)
*
|
2010-09-28 |
2012-02-08 |
太原理工大学 |
一种吡啶酮衍生物的制备方法
|
|
ES2536433T3
(es)
|
2010-11-08 |
2015-05-25 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
|
US9271967B2
(en)
|
2010-11-08 |
2016-03-01 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
|
AU2011328203B2
(en)
|
2010-11-08 |
2015-03-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
|
US8507499B2
(en)
|
2010-12-06 |
2013-08-13 |
Confluence Life Sciences, Inc. |
Substituted indole/indazole-pyrimidinyl compounds
|
|
WO2012078673A1
(en)
|
2010-12-06 |
2012-06-14 |
Confluence Life Sciences, Inc. |
Substituted pyridine urea compounds
|
|
US9359300B2
(en)
|
2010-12-06 |
2016-06-07 |
Confluence Life Sciences, Inc. |
Methyl/difluorophenyl-methoxy substituted pyridinone-pyridinyl compounds, methyl-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds, and methyl-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds
|
|
SI2648516T1
(sl)
|
2010-12-06 |
2019-01-31 |
Aclaris Therapeutics, Inc. |
Substituirane spojine piridinon-piridinila
|
|
ES2626457T3
(es)
*
|
2011-03-07 |
2017-07-25 |
Pfizer Inc. |
Derivados de fluoro-piridinona útiles como agentes antibacterianos
|
|
JP2014507474A
(ja)
|
2011-03-08 |
2014-03-27 |
オースペックス・ファーマシューティカルズ・インコーポレイテッド |
置換ｎ−アリールピリジノン
|
|
AU2012301953C1
(en)
*
|
2011-08-29 |
2016-11-03 |
Ptc Therapeutics, Inc. |
Antibacterial compounds and methods for use
|
|
HK1199792A1
(en)
*
|
2011-08-29 |
2015-07-24 |
Ptc Therapeutics, Inc. |
Antibacterial compounds and methods for use
|
|
WO2013057101A1
(de)
|
2011-10-17 |
2013-04-25 |
Bayer Intellectual Property Gmbh |
Substituierte oxadiazolylpyridinone und - pyridazinone als hif - hemmer
|
|
JP2015504307A
(ja)
|
2011-11-22 |
2015-02-12 |
インターミューン， インコーポレイテッド |
特発性肺線維症を診断および治療する方法
|
|
US9056110B2
(en)
|
2011-12-06 |
2015-06-16 |
Confluence Life Sciences, Inc. |
Substituted pyrimidinone-phenyl-pyrimidinyl compounds
|
|
US9732085B2
(en)
|
2011-12-21 |
2017-08-15 |
Ono Pharmaceutical Co., Ltd. |
Pyridinone and pyrimidinone derivatives as factor Xia
|
|
US9365540B2
(en)
*
|
2012-01-12 |
2016-06-14 |
Takeda Pharmaceutical Company Limited |
Benzimidazole derivatives as MCH receptor antagonists
|
|
DK2820009T3
(en)
*
|
2012-03-01 |
2018-04-16 |
Array Biopharma Inc |
Serine / threonine kinase inhibitors
|
|
CN103288719A
(zh)
*
|
2012-03-05 |
2013-09-11 |
苏州欧凯医药技术有限公司 |
非核甘艾滋病毒抑制物-吡啶酮类先导体的合成
|
|
JP5924984B2
(ja)
*
|
2012-03-06 |
2016-05-25 |
国立大学法人東京農工大学 |
トリフルオロメチルピリジノン化合物およびその製造方法
|
|
BR112014030284B1
(pt)
|
2012-07-18 |
2021-11-30 |
Sunshine Lake Pharma Co., Ltd |
Composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
|
|
WO2014031928A2
(en)
*
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
|
BR112015003729A2
(pt)
|
2012-08-24 |
2018-06-05 |
Univ Texas |
composto de fórmula estrutural i; composição farmacêutica; método de tratamento de uma doença mediada por caminho do hif; método de tratamento de uma doença causada por proliferação anormal de células; e método para alcançar um efeito em um paciente
|
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
|
PL2931716T3
(pl)
|
2012-12-13 |
2017-04-28 |
Novartis Ag |
Pochodne pirydonu i ich zastosowanie w leczeniu gruźlicy
|
|
RS56015B1
(sr)
|
2013-01-31 |
2017-09-29 |
Vertex Pharma |
Piridon amidi kao modulatori natrijumovih kanala
|
|
WO2014181213A1
(en)
|
2013-05-10 |
2014-11-13 |
Pfizer Inc. |
Crystalline form of (sa)-(-)-3-(3-bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1 (2h)-yl)-n,4-dimethylbenzamide
|
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
|
HUE054178T2
(hu)
|
2013-06-07 |
2021-08-30 |
Aclaris Therapeutics Inc |
Metil/fluor-piridinil-metoxi-szubsztituált piridinon-piridinil-vegyületek és fluor-pirimidinil-metoxi-szubsztituált piridinon-piridinil-vegyületek
|
|
US9199963B2
(en)
|
2013-07-09 |
2015-12-01 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
|
CA2931550C
(en)
|
2013-12-13 |
2023-09-26 |
Vertex Pharmaceuticals Incorporated |
Prodrugs of pyridone amides useful as modulators of sodium channels
|
|
ME03518B
(me)
|
2014-01-21 |
2020-04-20 |
Janssen Pharmaceutica Nv |
Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
|
|
MX386697B
(es)
|
2014-01-21 |
2025-03-19 |
Janssen Pharmaceutica Nv |
Combinaciones que comprenden agonistas ortostericos o moduladores alostericos positivos del receptor glutamatergico metabotropico de subtipo 2 y su uso
|
|
US9663504B2
(en)
|
2014-02-25 |
2017-05-30 |
Board Of Regents, The University Of Texas System |
Salts of heterocyclic modulators of HIF activity for treatment of disease
|
|
MX382781B
(es)
|
2014-04-02 |
2025-03-13 |
Intermune Inc |
Piridinonas anti-fibroticas.
|
|
PT3174852T
(pt)
*
|
2014-07-30 |
2018-10-23 |
Abac Therapeutics S L |
Aril-hidrazidas contendo uma unidade 2-piridona como agentes antibacterianos seletivos
|
|
BR112017012146B1
(pt)
|
2014-12-10 |
2023-11-21 |
Ono Pharmaceutical Co., Ltd |
Composto derivado de di-hidroindolizinona, seu uso, composição farmacêutica e inibidor de fxia
|
|
PL3303330T3
(pl)
*
|
2015-06-03 |
2019-10-31 |
Bristol Myers Squibb Co |
Agoniści 4 - hydroksy - 3 - ( heteroarylo ) pirydyno - 2 - onowi receptora apj do stosowania w leczeniu zaburzeń sercowo-naczyniowych
|
|
CN105153027A
(zh)
*
|
2015-07-21 |
2015-12-16 |
东华大学 |
一种3-氰基-4-羟基-2-吡啶酮类化合物及其制备和应用
|
|
CN106466318B
(zh)
*
|
2015-08-21 |
2019-01-01 |
中南大学 |
1-杂环取代苄基吡啶酮类化合物在制备治疗糖尿病肾病药物中的应用
|
|
US20190060286A1
(en)
|
2016-02-29 |
2019-02-28 |
University Of Florida Research Foundation, Incorpo |
Chemotherapeutic Methods
|
|
EP3625214B1
(en)
|
2017-05-16 |
2022-07-06 |
Vertex Pharmaceuticals Incorporated |
Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
|
|
KR102236356B1
(ko)
|
2017-11-24 |
2021-04-05 |
주식회사 종근당 |
루푸스의 예방 또는 치료를 위한 조성물
|
|
US11529337B2
(en)
|
2018-02-12 |
2022-12-20 |
Vertex Pharmaceuticals Incorporated |
Method of treating pain
|
|
KR20190099952A
(ko)
*
|
2018-02-20 |
2019-08-28 |
주식회사 종근당 |
포도막염의 예방 또는 치료를 위한 조성물
|
|
JP7646643B2
(ja)
*
|
2019-10-04 |
2025-03-17 |
アンスティトゥート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシャルシュ・メディカル・（インセルム） |
新規なピリジン－２（１ｈ）オン誘導体、その調製、及び疼痛を処置するためのその使用
|
|
BR112022010924A2
(pt)
|
2019-12-06 |
2022-09-06 |
Vertex Pharma |
Tetra-hidrofuranos substituídos como moduladores de canais de sódio
|
|
GB201918413D0
(en)
|
2019-12-13 |
2020-01-29 |
Z Factor Ltd |
Compounds and their use for the treatment of alpha1-antitrypsin deficiency
|
|
KR20220161396A
(ko)
|
2020-03-27 |
2022-12-06 |
어클라리스 쎄라퓨틱스, 인코포레이티드 |
치환된 피리디논-피리디닐 화합물의 제조, 조성물, 및 결정형
|
|
JP2021183587A
(ja)
|
2020-05-22 |
2021-12-02 |
武田薬品工業株式会社 |
複素環化合物
|
|
CN112552232B
(zh)
*
|
2020-12-16 |
2022-11-25 |
浙江工业大学 |
一种吡啶酮六位炔胺修饰衍生物及其制备方法与应用
|
|
US12378229B2
(en)
|
2021-02-02 |
2025-08-05 |
Liminal Biosciences Limited |
GPR84 antagonists and uses thereof
|
|
BR112023019861A2
(pt)
*
|
2021-03-31 |
2023-11-07 |
Xinthera Inc |
Inibidores de mk2 e usos dos mesmos
|
|
SMT202500481T1
(it)
|
2021-06-04 |
2026-01-12 |
Vertex Pharma |
N-(idrossialchil(etero)aril)tetraidrofuran carbossammidi come modulatori di canali del sodio
|
|
EP4367099A4
(en)
*
|
2021-07-09 |
2025-06-04 |
Xinthera, Inc. |
Pyridinone mk2 inhibitors and uses thereof
|
|
CN116444493A
(zh)
*
|
2022-01-14 |
2023-07-18 |
上海翰森生物医药科技有限公司 |
含双并环类衍生物、其制备方法和应用
|
|
CN119546296B
(zh)
*
|
2022-07-28 |
2026-03-24 |
深圳信立泰药业股份有限公司 |
一种式（i）所示的三联吡啶二酮化合物晶型及其制备方法与应用
|